ArticleBulletin of the National Research Centre2023
Is monkeypox going to be the next pandemic?
Article in Bulletin of the National Research Centre, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Risk perception and mpox vaccine acceptability among people living with HIV in northern Nigeria.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2025Article
- Clade Ib: a new emerging threat in the Mpox outbreak.Frontiers in pharmacology · 2024Review
- Monkeypox virus (MPXV): A Brief account of global spread, epidemiology, virology, clinical features, pathogenesis, and therapeutic interventions.Infectious medicine · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aims: In the current global scenario, the monkeypox virus has infected over 3000 individuals from endemic countries like Nigeria, along with non-endemic countries like the UK, Canada, the USA, etc. Based on the current information, it has been observed that monkeypox cases have primarily, though not exclusively, been found among men who have sex with men (MSM) in countries such as the UK. This article discusses the recent outbreak of monkeypox, its causes, and the various approaches to combat monkeypox infections. Methods: We evaluated the trends of recent outbreaks of monkeypox in different countries and compared them to how the COVID-19 pandemic started. Results: At present, monkeypox has been reported to spread to over 58 countries via skin-to-skin contact, body fluids, contaminated bed sheets, clothing, or respiratory routes. Smallpox vaccines have been proven to have 85% efficacy against monkeypox. To mitigate this current outbreak, WHO urges people to practice good hygiene and safe sex. The documentation of more cases and further onward spread in the countries in member states are most likely to reoccur, and if not contained, we might experience another global pandemic. Therefore, more research is required to avert this problem. Conclusion: Monkeypox virus is testing if we have complied with COVID-19 pandemic lessons and elucidates the urgency of research required to understand the monkeypox disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.